Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed Papers
Breastfeeding and multiple sclerosis relapses: a meta-analysis.
Relapses Requiring Intravenous Steroid Use and Multiple-Sclerosis-Related Hospitalizations: Integrated Analysis of the Delayed-Release Dimethyl Fumarate Phase III Studies.
Aubagio® significantly reduced risk of new clinical relapse or MRI lesion in multiple sclerosis study
TH1/TH2 Cytokine profile in relapsing-remitting multiple sclerosis patients treated with Glatiramer acetate or Natalizumab.
Synthetic Biologics announces issuance of U.S. patent covering combination of estriol and Copaxone® for multiple sclerosis
Pharmacokinetics and metabolism of mitoxantrone. A review.
[Flow cytometry model for the detection of neutralizing antibodies against of IFN-β].
Spotlight on teriflunomide.
Regulation of astrocyte activation by glycolipids drives chronic CNS inflammation.
Pathogenic aquaporin-4 reactive T cells are sufficient to induce mouse model of neuromyelitis optica.
Covis Pharma to Acquire U.S. Rights from Sanofi for Nilandron®, Plaquenil®, Rilutek®, Uroxatral®, and Kayexalate®
Adeona Announces Completion of Planned Enrollment in Phase II Multiple Sclerosis Clinical Trial
Oligodendrocytes and progenitors become progressively depleted within chronically demyelinated lesions.
European Commission approves Genzyme’s multiple sclerosis treatment Lemtrada™ (alemtuzumab)
Consensus statement on the treatment of multiple sclerosis by the Spanish Society of Neurology in 2016.
Gene-expression signatures: biomarkers toward diagnosing multiple sclerosis.
Decreased systemic IL-7 and soluble IL-7Rα in multiple sclerosis patients.
From High- to Low-Frequency Administered Interferon-Beta for Multiple Sclerosis: A Multicenter Study.
Dimethylfumarate inhibits tumor-necrosis-factor-induced CD62E expression in an NF-kappa B-dependent manner.
Dendritic cell, monocyte and T cell activation and response to glatiramer acetate in multiple sclerosis.
Avonex approval application
Effirma, Synthetic Biologics
Myelin Oligodendrocyte Glycoprotein-Associated Pediatric Central Nervous System Demyelination: Clinical Course, Neuroimaging Findings, and Response to Therapy.
Multiple sclerosis: pathogenesis and treatment.
Influence of infection on exacerbations of multiple sclerosis.
Pages
« first
‹ previous
…
24
25
26
27
28
29
30
31
32
…
next ›
last »